Tetra Pharm Technologies Relocates to Copenhagen Towers

COPENHAGEN, Denmark, Sept. 18, 2024 /PRNewswire/ — Tetra Pharm Technologies are thrilled to announce the relocation of headquarters to Copenhagen Towers in Copenhagen. Effective October 1st, 2024, this strategic move reflects the company´s commitment to growth, accessibility, and collaboration.

“Driven by our vision for innovation, we’ve chosen Copenhagen Towers as our new home. Its vibrant business ecosystem and exceptional amenities align perfectly with our mission”, says Jesper Breum, COO, Tetra Pharm Technologies.

Copenhagen Towers, strategically positioned in Copenhagen, offers unparalleled connectivity. Proximity to major transportation hubs, such as Copenhagen airport, ensures seamless interactions with partners, clients, and stakeholders.

Collaborations and partnerships within the pharmaceutical industry, as well as with research institutions and regulatory agencies, are driving drug innovation.

“By combining expertise, sharing resources, and fostering knowledge exchange, collaborations are cultivating innovation and propelling advancements in healthcare”, CEO Martin Rose states.

Designed by Foster & Partners, the Towers embody Tetra Pharm´s commitment to cutting-edge solutions.

Tetra Pharm Technologies’ management, employees, and partners eagerly anticipate this transition.

“We invite everyone to join us in this exciting chapter.” Martin Rose adds.

The official move to Copenhagen Towers is scheduled for October 1st, 2024.

For media inquiries contact:

PR Manager Tue Wettergreen Paltorp
Email: tue.paltorp@tetrapharm.eu
Phone: +45-31441969

Photo – https://healthtechnologynet.com/wp-content/uploads/2024/09/Copenhagen_Towers.jpg
Logo – https://healthtechnologynet.com/wp-content/uploads/2024/09/TPT_Logo.jpg

View original content to download multimedia:https://www.prnewswire.com/news-releases/tetra-pharm-technologies-relocates-to-copenhagen-towers-302249209.html

SOURCE Tetra Pharm Technologies

Staff

Recent Posts

TVM Capital Healthcare Announces Investment in Human Longevity, Inc. as Part of its Strategy of Supporting Disease Prevention and Healthy Aging

HLI is one of the most established, global longevity science companies and committed to accelerating…

33 mins ago

Clarivate Announces 15th Annual Pharmavision India Conference Agenda

Industry leaders to discuss AI in healthcare, cell and gene therapy, market access and more…

33 mins ago

Xtant Medical Expands Product Portfolio with Launch of its own Viable Bone Matrix, OsteoVive(R) Plus

New Cellular Bone Matrix Designed with Cohesive and Moldable Handling Characteristics BELGRADE, MT / ACCESSWIRE…

33 mins ago

Bioz Stars Revolutionizes Product Selection in Scientific Research With Objective Ratings

PALO ALTO, CA / ACCESSWIRE / September 18, 2024 / Bioz, Inc., a pioneer in…

33 mins ago

IRLAB Granted Additional Patent for its Drug Candidate Pirepemat Expanding the Patent Protection in the US

GOTHENBURG, SE / ACCESSWIRE / September 18, 2024 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA) Gothenburg, Sweden,…

4 hours ago

Relief Therapeutics Completes Clinical Phase in RLF-OD032 Proof-of-Concept Study; Topline Results Expected in October 2024

GENEVA, SWITZERLAND / ACCESSWIRE / September 18, 2024 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY )…

4 hours ago